Login / Signup

Ensuring the strict and accurate adherence to inclusion criteria in clinical trials for AMD is crucial.

Enrico BorrelliMichele ReibaldiFrancesco BandelloPaolo LanzettaFrancesco Boscia
Published in: Eye (London, England) (2024)
Keyphrases
  • clinical trial
  • high resolution
  • phase ii
  • age related macular degeneration
  • open label
  • glycemic control
  • phase iii
  • study protocol
  • double blind
  • randomized controlled trial
  • metabolic syndrome